Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 200-820-0 | CAS number: 74-89-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates ā in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Dermal absorption
Administrative data
- Endpoint:
- dermal absorption in vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- not reported, published 1993
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Acceptable, well-documented publication which meets basic scientific principles
Data source
Reference
- Reference Type:
- publication
- Title:
- Do the Hydrolysis Products, Methylamine and N,Nā-Dimethylurea, Play any Role in the Methyl Isocyanate- Induced Haematological and Biochemical Changes in Rabbits?
- Author:
- Jeevaratnam, K., Sugendran, K., and Vaidyanathan, C.S.
- Year:
- 1 993
- Bibliographic source:
- Human &Experimental Toxicology, 12, 135-139
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 427 (Skin Absorption: In Vivo Method)
- Deviations:
- yes
- Principles of method if other than guideline:
- The test substance was administered subcutaneously and intravenously to the test animals.
- GLP compliance:
- no
Test material
- Reference substance name:
- Methylamine
- EC Number:
- 200-820-0
- EC Name:
- Methylamine
- Cas Number:
- 74-89-5
- Molecular formula:
- CH5N
- IUPAC Name:
- methanamine
- Details on test material:
- Methylamine (MA), 40% aqueous solution was obtained from E. Merck (India) and stored in a refrigerator because of its low boiling point.
Constituent 1
- Radiolabelling:
- no
Test animals
- Species:
- rabbit
- Strain:
- other: New Zealand
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- All animals were fasted over night and during the experiment, but water was allowed ad-libitum.
Administration / exposure
- Type of coverage:
- other: subcutaneous and intravenous
- Vehicle:
- water
- Duration of exposure:
- single injection
- Doses:
- 2.2 mmol/kg, s.c. and (iv)
- No. of animals per group:
- 6
- Control animals:
- yes
- Remarks:
- olive oil (injected)
- Details on study design:
- Blood (-0.6 ml) was drawn through a fine incision on the ear marginal vein into tubes containing heparin at 0 h (before treatment) and at 1 h, 4 h and 24 h (after treatment). Blood haemoglobin (Hb) concentration was determined by the standard cyanmethaemoglobin method and the erythrocyte volume fraction by the microhaematocrit method. Total leucocytes were counted by light microscopy using a Neubauer chamber.Total plasma protein was determined by the method of Lowry et al. and plasma albumin by the method of Doumas et al. Plasma urea was estimated by the manual diacetyl monooxime (DAM) method (cited in the original paper).
Results and discussion
- Signs and symptoms of toxicity:
- no effects
- Remarks:
- MA and DMU did not alter blood pyruvate and lactate levels. MA had no effect on the plasma urea level.
- Dermal irritation:
- no effects
Percutaneous absorption
- Remarks on result:
- other: not examined
- Conversion factor human vs. animal skin:
- not applicable
Any other information on results incl. tables
Of the six rabbits administered 1.0 LD 50 MIC (methyl isocyanate), two died. There were no deaths in the other groups. Rabbits administered MIC s.c. showed symptoms of respiratory distress while those animals which received either MA or DMU s.c. at equimolar concentration to MIC, appeared normal without any noticeable respiratory distress. A statistically significant increase in mean blood Hb concentration, erythrocyte volume fraction and leucocyte number was observed soon after MIC administration, the maximums being reached at 4 h while both MA and DMU administration did not affect these parameters. Plasma total protein increased significantly reaching a maximum (a 50% increase) after 4 h of MIC administration, while plasma albumin decreased with time. Both MA and DMU had no influence on either plasma total protein or plasma albumin. Furthermore, MA and DMU did not alter blood pyruvate and lactate levels. The plasma urea was significantly higher throughout the study period, reaching nearly three times the normal level 24 h after MIC administration. MA had no effect on the plasma urea level while DMU caused a marginal 20-30% increase early on and tended to return to normal by 24 h.
Applicant's summary and conclusion
- Conclusions:
- Methylamine (MMA) if administered subcutaneous to the rabbits did not induce haematological and biochemical changes. MMA had no influence on either plasma total protein or plasma albumin.MA did not alter blood pyruvate & lactate levels. Additionally no effects on the plasma urea level occurred.
- Executive summary:
Jeevaratnam et al. administered methylamine in 1993 subcutaneous to the animals to investigate whether the observed haematological and biochemical changes observed after MIC administration to the rabbits were due only to MIC itself or if its hydrolysis metabolites play any role in these effects. Both MA and DMU administered subcutaneously in an equimolar dose to that of 1.0 LD50 MIC, 2.2 mmol/kg had no influence on these parameters, although there was a marginal increase in the plasma urea level shortly after the administration of DMU. This study establishes that the observed hematological and biochemical changes induced by MIC intoxication in rabbits are mostly due to MIC.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.